Key result
A paced P-wave duration ≥160 ms was a strong predictor of developing atrial high-rate episodes lasting >24 hours in patients with CIEDs (OR 4.2; 95% CI 1.6-11.4; p=0.004).
Why the study?
Atrial pacing can unmask or aggravate preexisting interatrial block, but whether it is associated with developing atrial high-rate episodes was unclear.
Does prolonged paced P-wave duration predict the development of atrial high-rate episodes in patients with dual-chamber CIEDs?
Cohort (n=220)
Does prolonged paced P-wave duration predict the development of atrial high-rate episodes in patients with dual-chamber CIEDs?
A paced P-wave duration of ≥160 ms is a strong predictor of atrial high-rate episodes in patients with dual-chamber CIEDs, suggesting its utility as a marker for interatrial block and future arrhythmia risk.
Introduction: Atrial pacing can unmask or aggravate a preexisting interatrial block (IAB). Our study aimed to determine whether atrial pacing is associated with the development of atrial high-rate episodes (AHRE) during follow-up. Methods and Results: Patients with dual-chamber cardiac implantable electronic devices (CIED), no previous documented atrial fibrillation, and with a 6-month minimum follow-up were included. In all patients, sinus and paced P-wave duration was measured. AHRE was defined as an episode of atrial rate ≥ 225 bpm with a minimum duration of 5 min, excluding those documented during the first three months after implantation. Two hundred twenty patients were included (75 ± 10 years, 61% male). After a mean follow-up of 59±25 months, 46% of patients presented AHRE. Mean paced P-wave duration was significantly longer than the sinus P-wave duration (154±27 vs 115±18 ms; p < 0.001). Sinus and paced P-waves were significantly longer in those who developed AHRE (sinus: 119±20 vs 112±16; p = 0.006; paced: 161±29 vs 148±23; p < 0.001). A paced P-wave ≥160 ms was the best predictor of AHRE, especially those lasting >24 h (OR 4.2 (95% CI) [1.6-11.4]; p = 0.004). Conclusion: Atrial pacing significantly prolongs P-wave duration and is associated with further development of AHRE. A paced P-wave ≥160 ms is a strong predictor of AHRE and should be taken into consideration as a new definition of IAB in the presence of atrial pacing.
No takes yet. Share an insight, caveat, or question.
Campal et al. (2021) conducted a cohort in Patients with dual-chamber cardiac implantable electronic devices (CIED) (n=220). Paced P-wave duration ≥160 ms vs. Paced P-wave duration <160 ms was evaluated on Atrial high-rate episodes (AHRE) lasting >24 h (OR 4.2, 95% CI 1.6-11.4, p=0.004). A paced P-wave duration ≥160 ms was a strong predictor of developing atrial high-rate episodes lasting >24 hours in patients with CIEDs (OR 4.2; 95% CI 1.6-11.4; p=0.004).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: